Tony Gershlick

Jazz interventionalist specialising in coronary reconstruction

[Tony Gershlick @agershlick]

COVIDACSGLOBALREGISTRY is live!
Contact [email protected]
if you wish to contribute to our understanding. We will then send you link to the Registry webase.We will share final data. Great work Uni Glasgow and Leicester. @SVRaoMD @GreggWStone @mmamas1973 @DLBHATTMD

[Tony Gershlick @agershlick]

It can only be hypothysis generating Dont over rinterpret

[Nicholas Mills @HighSTEACS]

#RAPIDCTCA #AHA2020 Significant reduction in invasive coronary angiography with no evidence of harm in acute coronary syndrome. Need to look at cost effectiveness and learn from this trial and others how to select patients for #CTCA

[Tony Gershlick @agershlick]

@aayshacader @AHAMeetings @mirvatalasnag @andrew_ludman @DrDerekConnolly @HighSTEACS @ncurzen @drtomkite @VijayKunadian @DrMarthaGulati @purviparwani @chadialraies @biljana_parapid Interesting and important study mostly at trying to work out who doesn't need inv angiography...vulnerable plaque sensitivity w CTCA may be the issue of course

[Tony Gershlick @agershlick]

These are relevant issues to us as cardiologists working in a world where all sorts of factors (systemic&local) other than than the obvious ones impact on outcomes in ACS patients. We have a stellar cast to discuss the impact of systemic inflammatory condition on ACS. Join us !!

[Millbrook Medical Conferences @MillbrookMed]

The Impact of Covid-19 Pandemic on Acute Coronary Syndromes e-conference goes live in less than 2 weeks

Wednesday 25 November
10:00 -17:00 GMT
FREE registration: https://t.co/hg0AeRVg8m

Speakers include @mmamas1973 @SukhNijjer Valentin Fuster, Bernard Gersh & more

Programme👇

[Tony Gershlick @agershlick]

Excellent..contribution ...

[RapidNSTEMI @RapidNSTEMI]

9⃣0⃣ randomised at Glenfield Hospital! @LeicResearch @Leic_hospital 🎉 Well done to Boby for randomising, PI @ALadwiniec and the rest of the fabulous team 🙌 #rapidteam #cardiologyresearch @TheBHF @agershlick @drtomkite

[Tony Gershlick @agershlick]

These posts have been hugely successful over the years The perfect blend of exposure to & involvement in high level CHIP PCI &TAVI with the underlying theme of evidence-based practice in a Unit that has for many years been at the cutting edge of clinical research trials. Join us

[Andrew Ladwiniec @ALadwiniec]

We have an interventional fellow post out at Glenfield Hospital, Leicester. @leic_hospital. An opportunity to train in complex PCI or structural intervention depending on interest and experience. @agershlick @ShaziaTHussain1 @Leic_hospital @BCIS_uk https://t.co/nBPVhA4jqm

[Tony Gershlick @agershlick]

Important trial

[Gregg W. Stone MD @GreggWStone]

Thrombosis is a major contributor to poor outcomes in COVID. We’re randomizing 3600 hosp’d but not intubated COVID-19 pts to diff anticoagulation regimens. Investigator-sponsored study, Valentin Fuster PI. If interested email [email protected] and [email protected].

[Tony Gershlick @agershlick]

Agree really important

[Prof Chris P Gale @cpgale3]

So, if you think you may be having a #heartattack , call 999 - don’t stay at home. https://t.co/5SG5Df0eEt

[Tony Gershlick @agershlick]

Joel Garner short ball pre helmets

[Mark Signy @Siggers1000]

@crickshouts Glenn McGrath bowling with Shane Warne

[Tony Gershlick @agershlick]

Good news

[RapidNSTEMI @RapidNSTEMI]

Congratulations @OUHospitals and PI Prof Adrian Banning. Today we've given 🟢 light to John Radcliffe Hospital to resume recruitment for @RapidNSTEMI, bringing us to a total of 2⃣1⃣ open sites! 🎉#rapidteam #cardiologyresearch #happyfriday @agershlick @drtomkite

[Tony Gershlick @agershlick]

Great incentive BCIS

[curzen @ncurzen]

Let’s celebrate UK interventional research

[Tony Gershlick @agershlick]

Great effort Salvador, Adnan Kastrsti and team in Munich .. EURO SHOCK train is rolling ...@mmamas1973 @GreggWStone @cpgale3

[EUROSHOCK @EUROSHOCKstudy]

Congratulations to @adnan_kastrati and his team at DHM for recruiting their 1st patient to our #H2020 trial! @agershlick #cardiotwitter @UoLCVS

[Tony Gershlick @agershlick]

Thats the one Tom !!!

[Tom Quinn etc. @proftomquinn]

@cpgale3 @agershlick https://t.co/FsrPCoxVW8

[Tony Gershlick @agershlick]

There's a planned pilot study of roadside ECMO ..good job you weren't called to that !!

[Prof Chris P Gale @cpgale3]

Just had the village #defibrillator out. Thankfully, didn’t need to use it. Patient now en route to hospital.

[Tony Gershlick @agershlick]

We agree then No targets unless scientifically targeted but this is a priority aim

[jcspratt @jcspratt]

@agershlick Yes agree that targets need to have some validity, but absence of validated targets is responsible for the variability of care currently damaging the field.

[Tony Gershlick @agershlick]

Agree of course and not advocating qualitative assessment when there is uncertainty. However your proposed "objective targets" need to be proven to be more than a randomly plucked number and should have impact ..POEM..patient oriented hard outcomes I am sure you agree

[jcspratt @jcspratt]

@agershlick Flip side of that is that without clear, objective targets (MSA / iFR) a successful Intervention is defined in binary terms as stent implantation or visual estimation of flow.

[Tony Gershlick @agershlick]

Real danger is the chasing of a number (>0.95)that needs to be proven to be beneficial w/out leading to the obvious risk of complications including edge tears and sent disruption, not to mention cost. Too early to promote a number. eg ill be interest. to see if focal 0.9=hard EP

[Gregg W. Stone MD @GreggWStone]

@ajaykirtane @MitulKanzariaMD @DrAllenJ @manesh_patelMD Regarding increased stent usage, it will depend on the cause of the residual gradient. It may only require a larger or higher pressure balloon inflation. If focal, e.g. an unrealized edge dissection or unseen focal stenosis it might require a new stent - but that's a good thing.

[Tony Gershlick @agershlick]

Thanks for this comment-the trial is testing 1 strategy but at different times therefore IF the results are +ve for v early then that will be generalizable if PCI for N-STEMI is available in that country. Also our patient population are very heterogenous within the incl criteria

[Dr Sana Sheikh @sana_epienthu]

@RapidNSTEMI @LeedsHospitals @LeedsPci @agershlick @drtomkite @RapidNSTEMI
the trial is investigating an important clinical management which may result in change in guidelines. Will the investigators consider expanding it later to LMICs to make it more generalizable?

[EUROSHOCK @EUROSHOCKstudy]

Later today, Manel Sabate @idibaps will present our #H2020 EURO SHOCK study at #ECMOBARNA2020 Many thanks to @ECMOHUVH for giving us the platform to spread the word about this very important project!

[Tony Gershlick @agershlick]

Brilliant job. Well done to all, espec research nurses, non-GCP nurses, PIs, and hard work of CTU team and Fellow @drtomkite and @TheBHF for their support- not forgetting the patients who trust us to do clinical trial to high research governance. Ever onwards-let's get it done!

[RapidNSTEMI @RapidNSTEMI]

Some exciting news coming!! Can you guess what? 😃🎉🙌#cardiologyresearch #rapidteam @agershlick @drtomkite

[RapidNSTEMI @RapidNSTEMI]

Who will take us to 400? #evenourlogoisexcited 👀😂 #rapidteam #cardiologyresearch @agershlick @drtomkite